| __timestamp | Bio-Techne Corporation | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 12122000 |
| Thursday, January 1, 2015 | 40853000 | 13380000 |
| Friday, January 1, 2016 | 45187000 | 21221000 |
| Sunday, January 1, 2017 | 53514000 | 26887000 |
| Monday, January 1, 2018 | 55329000 | 27863000 |
| Tuesday, January 1, 2019 | 62413000 | 55908000 |
| Wednesday, January 1, 2020 | 65192000 | 59392000 |
| Friday, January 1, 2021 | 70603000 | 69012000 |
| Saturday, January 1, 2022 | 87140000 | 36082000 |
| Sunday, January 1, 2023 | 92493000 | 24537000 |
| Monday, January 1, 2024 | 96664000 |
Cracking the code
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Bio-Techne Corporation and Ligand Pharmaceuticals Incorporated have demonstrated contrasting trends in their R&D investments. From 2014 to 2023, Bio-Techne's R&D expenses surged by approximately 212%, reflecting a robust focus on innovation. In contrast, Ligand Pharmaceuticals saw a peak in 2021, with a subsequent decline of around 65% by 2023. This divergence highlights Bio-Techne's consistent growth strategy, while Ligand's fluctuating investments suggest a more variable approach. The data for 2024 remains incomplete, leaving room for speculation on future trends. As the biotech sector continues to expand, understanding these spending patterns offers valuable insights into each company's strategic priorities and potential for future breakthroughs.
Comparing Innovation Spending: Novo Nordisk A/S and Bio-Techne Corporation
Comparing Innovation Spending: Johnson & Johnson and Bio-Techne Corporation
R&D Spending Showdown: Zoetis Inc. vs Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
Bio-Techne Corporation vs Iovance Biotherapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Grifols, S.A. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated